Presentation

REAL-WORLD DEMOGRAPHIC AND TREATMENT CHARACTERISTICS OF PATIENTS WITH CONGENITAL MYASTHENIC SYNDROME IN THE UNITED STATES

Mar 18, 2026, 21:38 PM
A COMPARISON OF DIRECT MEDICAL COSTS IN VERTEBROPLASTY AND KYPHOPLASTY IN JAPAN AND IMPLICATIONS FOR IMPACTS ON THE BUDGET

Mar 18, 2026, 21:38 PM
IMPROVING AN ADHERENT PATIENT ANALYSIS OF THE DIABETES PREVENTION PROGRAM AND OUTCOMES STUDY

Mar 18, 2026, 21:38 PM
REAL-WORLD TREATMENT PATTERNS AND TREATMENT INTENSIFICATION IN METASTATIC HORMONE-SENSITIVE PROSTATE CANCER (MHSPC) BY DISEASE VOLUME AND PRESENTATION

Mar 18, 2026, 21:38 PM
THE IMPACT OF PHYSICAL FUNCTION ON HEALTHCARE RESOURCE USE AND CLINICAL OUTCOMES IN PATIENTS WITH HEART FAILURE: A UK BIOBANK STUDY

Mar 18, 2026, 21:38 PM
EVALUATION OF MACHINE LEARNING-ASSISTED DATA EXTRACTION FOR SUPPORTING SYSTEMATIC REVIEWS.VA CASE STUDY OF A REVIEW IN MOVEMENT DISORDERS

Mar 18, 2026, 21:38 PM
ECONOMIC EVALUATION AND BUDGET IMPACT ANALYSIS OF MICROWAVE ABLATION VS. RADIOFREQUENCY ABLATION AND SURGICAL RESECTION FOR EARLY-STAGE HEPATOCELLULAR CARCINOMA IN THE MEXICAN PUBLIC HEALTH SYSTEM

Mar 18, 2026, 21:38 PM
COST-EFFECTIVENESS OF LATENT TUBERCULOSIS INFECTION INTERVENTIONS IMPLEMENTED DURING THE TUBERCULOSIS EPIDEMIOLOGIC STUDIES CONSORTIUM (TBESC-III)

Mar 18, 2026, 21:38 PM
USE OF REAL-WORLD EVIDENCE IN PRE-APPROVAL ASSESSMENTS FOR RARE AND ULTRA-RARE DISEASE THERAPIES IN UK, GERMANY, FRANCE, AND THE UNITED STATES

Mar 18, 2026, 21:38 PM
REAL-WORLD DATABASES IN CHINA: REGIONAL LANDSCAPE, INTEGRATION CHALLENGES, AND METHODOLOGICAL PRACTICE

Mar 18, 2026, 21:38 PM
UNIT-CONSISTENT TRANSLATION OF TREATMENT EFFECTS INTO NUMBER NEEDED TO TREAT AND COST PER EVENT AVOIDED IN HEALTH ECONOMIC EVALUATIONS

Mar 18, 2026, 21:38 PM
FACTORS ASSOCIATED WITH TREATMENT ENGAGEMENT AMONG EMERGENCY DEPARTMENT PATIENTS WITH OPIOID USE DISORDER AFTER DISCHARGE: A RETROSPECTIVE COHORT STUDY

Mar 18, 2026, 21:38 PM
AGE AND GENDER HETEROGENEITY IN ADVERSE DRUG REACTIONS ASSOCIATED WITH HEMP USE: EVIDENCE FROM THE FDA PHARMACOVIGILANCE DATA IN THE LAST TWO DECADES

Mar 18, 2026, 21:38 PM
PATIENT EXPERIENCE AND NET PROMOTER SCORE IN A STRUCTURED DERMATOLOGICAL IMMUNOBIOLOGIC CARE MODEL: REAL-WORLD EVIDENCE TO SUPPORT VALUE-BASED HEALTHCARE

Mar 18, 2026, 21:38 PM
THE IMPACT OF PERIOPERATIVE IMMUNE CHECKPOINT INHIBITORS ON THE ECONOMIC BURDEN OF BLADDER CANCER IN CANADA

Mar 18, 2026, 21:38 PM
DRUG SHORTAGES FINAL RULE RETROSPECTIVE ANALYSIS

Mar 18, 2026, 21:38 PM
EXAMINING THE ASSOCIATION BETWEEN PROBLEMATIC INTERNET USE AND MENTAL HEALTH AMONG ADOLESCENTS

Mar 18, 2026, 21:38 PM
THE IMPACT OF CHRONIC KIDNEY DISEASE AND ANEMIA ON THE ASSOCIATION BETWEEN FASTING PLASMA GLUCOSE AND HBA1C LEVELS

Mar 18, 2026, 21:38 PM
DATA-DRIVEN BASELINE MATCHING: ENHANCING INDIRECT COMPARISONS WITH A MACHINE LEARNING-INFORMED FRAMEWORK FOR SELECTING HOMOGENEOUS TRIAL SETS

Mar 18, 2026, 21:38 PM
PREVALENCE, RISK FACTORS, AND SAFETY IMPLICATIONS OF POTENTIALLY INAPPROPRIATE MEDICATION USE AMONG OLDER ADULTS WITH DEMENTIA: A SYSTEMATIC REVIEW

Mar 18, 2026, 21:38 PM

Presentation (CTI)

REAL-WORLD DEMOGRAPHIC AND TREATMENT CHARACTERISTICS OF PATIENTS WITH CONGENITAL MYASTHENIC SYNDROME IN THE UNITED STATES

A COMPARISON OF DIRECT MEDICAL COSTS IN VERTEBROPLASTY AND KYPHOPLASTY IN JAPAN AND IMPLICATIONS FOR IMPACTS ON THE BUDGET

IMPROVING AN ADHERENT PATIENT ANALYSIS OF THE DIABETES PREVENTION PROGRAM AND OUTCOMES STUDY

REAL-WORLD TREATMENT PATTERNS AND TREATMENT INTENSIFICATION IN METASTATIC HORMONE-SENSITIVE PROSTATE CANCER (MHSPC) BY DISEASE VOLUME AND PRESENTATION

THE IMPACT OF PHYSICAL FUNCTION ON HEALTHCARE RESOURCE USE AND CLINICAL OUTCOMES IN PATIENTS WITH HEART FAILURE: A UK BIOBANK STUDY

EVALUATION OF MACHINE LEARNING-ASSISTED DATA EXTRACTION FOR SUPPORTING SYSTEMATIC REVIEWS.VA CASE STUDY OF A REVIEW IN MOVEMENT DISORDERS

ECONOMIC EVALUATION AND BUDGET IMPACT ANALYSIS OF MICROWAVE ABLATION VS. RADIOFREQUENCY ABLATION AND SURGICAL RESECTION FOR EARLY-STAGE HEPATOCELLULAR CARCINOMA IN THE MEXICAN PUBLIC HEALTH SYSTEM

COST-EFFECTIVENESS OF LATENT TUBERCULOSIS INFECTION INTERVENTIONS IMPLEMENTED DURING THE TUBERCULOSIS EPIDEMIOLOGIC STUDIES CONSORTIUM (TBESC-III)

USE OF REAL-WORLD EVIDENCE IN PRE-APPROVAL ASSESSMENTS FOR RARE AND ULTRA-RARE DISEASE THERAPIES IN UK, GERMANY, FRANCE, AND THE UNITED STATES

REAL-WORLD DATABASES IN CHINA: REGIONAL LANDSCAPE, INTEGRATION CHALLENGES, AND METHODOLOGICAL PRACTICE

UNIT-CONSISTENT TRANSLATION OF TREATMENT EFFECTS INTO NUMBER NEEDED TO TREAT AND COST PER EVENT AVOIDED IN HEALTH ECONOMIC EVALUATIONS

FACTORS ASSOCIATED WITH TREATMENT ENGAGEMENT AMONG EMERGENCY DEPARTMENT PATIENTS WITH OPIOID USE DISORDER AFTER DISCHARGE: A RETROSPECTIVE COHORT STUDY

AGE AND GENDER HETEROGENEITY IN ADVERSE DRUG REACTIONS ASSOCIATED WITH HEMP USE: EVIDENCE FROM THE FDA PHARMACOVIGILANCE DATA IN THE LAST TWO DECADES

PATIENT EXPERIENCE AND NET PROMOTER SCORE IN A STRUCTURED DERMATOLOGICAL IMMUNOBIOLOGIC CARE MODEL: REAL-WORLD EVIDENCE TO SUPPORT VALUE-BASED HEALTHCARE

THE IMPACT OF PERIOPERATIVE IMMUNE CHECKPOINT INHIBITORS ON THE ECONOMIC BURDEN OF BLADDER CANCER IN CANADA

DRUG SHORTAGES FINAL RULE RETROSPECTIVE ANALYSIS

EXAMINING THE ASSOCIATION BETWEEN PROBLEMATIC INTERNET USE AND MENTAL HEALTH AMONG ADOLESCENTS

THE IMPACT OF CHRONIC KIDNEY DISEASE AND ANEMIA ON THE ASSOCIATION BETWEEN FASTING PLASMA GLUCOSE AND HBA1C LEVELS

DATA-DRIVEN BASELINE MATCHING: ENHANCING INDIRECT COMPARISONS WITH A MACHINE LEARNING-INFORMED FRAMEWORK FOR SELECTING HOMOGENEOUS TRIAL SETS

PREVALENCE, RISK FACTORS, AND SAFETY IMPLICATIONS OF POTENTIALLY INAPPROPRIATE MEDICATION USE AMONG OLDER ADULTS WITH DEMENTIA: A SYSTEMATIC REVIEW

ISPOR–The Professional Society for
Health Economics and Outcomes Research

Your browser is out-of-date